Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

210.53
-0.5100-0.24%
Post-market: 210.530.00000.00%19:40 EDT
Volume:1.94M
Turnover:410.08M
Market Cap:10.68B
PE:33.35
High:212.62
Open:210.89
Low:209.84
Close:211.04
52wk High:217.12
52wk Low:144.65
Shares:50.75M
Float Shares:50.75M
Volume Ratio:1.36
T/O Rate:3.82%
Dividend:0.34
Dividend Rate:0.16%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.31
PE(LYR):5.96

Loading ...

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

GlobeNewswire
·
Yesterday

Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong

Dow Jones
·
Yesterday

Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang

TIPRANKS
·
Yesterday

Actinogen Medical Adds Modest Number of New Shares to ASX Listing

TIPRANKS
·
Yesterday

Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials

TIPRANKS
·
Yesterday

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Yesterday

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector

TIPRANKS
·
Yesterday

Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says

MT Newswires Live
·
Yesterday

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29

Reuters
·
Sep 29

Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium

MT Newswires Live
·
Sep 29

Sector Update: Healthcare Stocks Advance Pre-Bell Tuesday

MT Newswires Live
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

TIPRANKS
·
Sep 29

Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims

TIPRANKS
·
Sep 29

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

TIPRANKS
·
Sep 29

Citi: Sino Biopharmaceutical and STADA Form Biosimilar Strategic Partnership, "Buy" Rating Maintained

Stock News
·
Sep 29

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

Reuters
·
Sep 29

Rhythm Biosciences Files Updated Corporate Governance Statement With ASX

TIPRANKS
·
Sep 29

Sino Biopharmaceutical Jumps Nearly 4% as Subsidiary Strikes Strategic Biosimilar Deal with STADA, Securing Up to EUR53 Million in Upfront Payment

Stock News
·
Sep 29

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

TIPRANKS
·
Sep 29